313 related articles for article (PubMed ID: 30046003)
1. Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes.
Wong JC; Bryant V; Lamprecht T; Ma J; Walsh M; Schwartz J; Del Pilar Alzamora M; Mullighan CG; Loh ML; Ribeiro R; Downing JR; Carroll WL; Davis J; Gold S; Rogers PC; Israels S; Yanofsky R; Shannon K; Klco JM
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046003
[TBL] [Abstract][Full Text] [Related]
2. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations.
Ahmed IA; Farooqi MS; Vander Lugt MT; Boklan J; Rose M; Friehling ED; Triplett B; Lieuw K; Saldana BD; Smith CM; Schwartz JR; Goyal RK
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2186-2196. PubMed ID: 31306780
[TBL] [Abstract][Full Text] [Related]
4. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.
Davidsson J; Puschmann A; Tedgård U; Bryder D; Nilsson L; Cammenga J
Leukemia; 2018 May; 32(5):1106-1115. PubMed ID: 29535429
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of germline GATA2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7.
Yoshida M; Tanase-Nakao K; Shima H; Shirai R; Yoshida K; Osumi T; Deguchi T; Mori M; Arakawa Y; Takagi M; Miyamura T; Sakaguchi K; Toyoda H; Ishida H; Sakata N; Imamura T; Kawahara Y; Morimoto A; Koike T; Yagasaki H; Ito S; Tomizawa D; Kiyokawa N; Narumi S; Kato M
Br J Haematol; 2020 Dec; 191(5):835-843. PubMed ID: 32770553
[TBL] [Abstract][Full Text] [Related]
6. [Association between SAMD9/SAMD9L and hematological malignancies].
Narumi S; Hasegawa T
Rinsho Ketsueki; 2018; 59(11):2475-2480. PubMed ID: 30531146
[TBL] [Abstract][Full Text] [Related]
7. Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.
Thomas ME; Abdelhamed S; Hiltenbrand R; Schwartz JR; Sakurada SM; Walsh M; Song G; Ma J; Pruett-Miller SM; Klco JM
Leukemia; 2021 Nov; 35(11):3232-3244. PubMed ID: 33731850
[TBL] [Abstract][Full Text] [Related]
8. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes.
Sahoo SS; Pastor VB; Goodings C; Voss RK; Kozyra EJ; Szvetnik A; Noellke P; Dworzak M; Starý J; Locatelli F; Masetti R; Schmugge M; De Moerloose B; Catala A; Kállay K; Turkiewicz D; Hasle H; Buechner J; Jahnukainen K; Ussowicz M; Polychronopoulou S; Smith OP; Fabri O; Barzilai S; de Haas V; Baumann I; Schwarz-Furlan S; ; Niewisch MR; Sauer MG; Burkhardt B; Lang P; Bader P; Beier R; Müller I; Albert MH; Meisel R; Schulz A; Cario G; Panda PK; Wehrle J; Hirabayashi S; Derecka M; Durruthy-Durruthy R; Göhring G; Yoshimi-Noellke A; Ku M; Lebrecht D; Erlacher M; Flotho C; Strahm B; Niemeyer CM; Wlodarski MW
Nat Med; 2021 Oct; 27(10):1806-1817. PubMed ID: 34621053
[TBL] [Abstract][Full Text] [Related]
9. Constitutional
Pastor VB; Sahoo SS; Boklan J; Schwabe GC; Saribeyoglu E; Strahm B; Lebrecht D; Voss M; Bryceson YT; Erlacher M; Ehninger G; Niewisch M; Schlegelberger B; Baumann I; Achermann JC; Shimamura A; Hochrein J; Tedgård U; Nilsson L; Hasle H; Boerries M; Busch H; Niemeyer CM; Wlodarski MW
Haematologica; 2018 Mar; 103(3):427-437. PubMed ID: 29217778
[TBL] [Abstract][Full Text] [Related]
10. Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7.
Nagamachi A; Matsui H; Asou H; Ozaki Y; Aki D; Kanai A; Takubo K; Suda T; Nakamura T; Wolff L; Honda H; Inaba T
Cancer Cell; 2013 Sep; 24(3):305-17. PubMed ID: 24029230
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome.
Erlacher M; Andresen F; Sukova M; Stary J; De Moerloose B; Bosch JVWT; Dworzak M; Seidel MG; Polychronopoulou S; Beier R; Kratz CP; Nathrath M; Frühwald MC; Göhring G; Bergmann AK; Mayerhofer C; Lebrecht D; Ramamoorthy S; Yoshimi A; Strahm B; Wlodarski MW; Niemeyer CM
Haematologica; 2024 Feb; 109(2):422-430. PubMed ID: 37584291
[TBL] [Abstract][Full Text] [Related]
12. [Monosomy 7: recent progress].
Inaba T; Nagamachi A
Rinsho Ketsueki; 2019; 60(9):1020-1026. PubMed ID: 31597823
[TBL] [Abstract][Full Text] [Related]
13. Gain-of-function
Tesi B; Davidsson J; Voss M; Rahikkala E; Holmes TD; Chiang SCC; Komulainen-Ebrahim J; Gorcenco S; Rundberg Nilsson A; Ripperger T; Kokkonen H; Bryder D; Fioretos T; Henter JI; Möttönen M; Niinimäki R; Nilsson L; Pronk CJ; Puschmann A; Qian H; Uusimaa J; Moilanen J; Tedgård U; Cammenga J; Bryceson YT
Blood; 2017 Apr; 129(16):2266-2279. PubMed ID: 28202457
[TBL] [Abstract][Full Text] [Related]
14. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
[TBL] [Abstract][Full Text] [Related]
15. Revertant somatic mosaicism as a cause of cancer.
Inaba T; Nagamachi A
Cancer Sci; 2021 Apr; 112(4):1383-1389. PubMed ID: 33583097
[TBL] [Abstract][Full Text] [Related]
16. Multiorgan failure with abnormal receptor metabolism in mice mimicking Samd9/9L syndromes.
Nagamachi A; Kanai A; Nakamura M; Okuda H; Yokoyama A; Shinriki S; Matsui H; Inaba T
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33373325
[TBL] [Abstract][Full Text] [Related]
17. [Predisposition and progression of myelodysplastic syndromes].
Makishima H
Rinsho Ketsueki; 2021; 62(4):278-288. PubMed ID: 33967153
[TBL] [Abstract][Full Text] [Related]
18. The enigma of monosomy 7.
Inaba T; Honda H; Matsui H
Blood; 2018 Jun; 131(26):2891-2898. PubMed ID: 29615405
[TBL] [Abstract][Full Text] [Related]
19. Cord Blood Transplantation in 2 Infants Presenting Monosomy 7 Clonal Hematopoiesis: SAMD9 / SAMD9L Germline Mutation.
Hirai M; Yagasaki H; Kanezawa K; Ueno M; Shimozawa K; Imai K; Morio T; Kato M; Gocho Y; Narumi S; Ebihara Y; Morioka I
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e290-e293. PubMed ID: 36730951
[TBL] [Abstract][Full Text] [Related]
20. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
